Case study: Shunt relieves pressure from arachnoid brain cyst, allowing boy to continue leukemia treatment
The patient A 4-year-old boy presented to the hospital with fever, fatigue and weakness. He also complained of blurry vision. He had recently had nose bleeds and oral bleeding. A complete blood count showed pancytopenia, [...]
View more
Pediatricians’ primer on childhood CNS tumors
Tumors in the central nervous system (CNS) account for 20% of childhood cancers, with 5.65 cases and 0.72 deaths per 100,000 children under 14 in the United States. Brain tumors are second only to acute […]
View more
MEK Inhibitor shrinks large hypothalamic enhancing tumor in teen
The patient A 14-year-old female presented with worsening headache and deterioration of vision especially in the left eye. MRI detected a large hypothalamic enhancing tumor causing mass effect on the optic nerves. The pituitary gland […]
View more
Classification and treatment of pediatric cancerous brain tumor, medulloblastoma
Medulloblastoma is one of the most common malignant brain tumors in children, with cases tending to surface around ages 4 or 5. Currently, the treatment protocol is resection of as much of the tumor as […]
View more
Diagnosing and treating brain tumors in children
There are many types and subtypes of brain tumors in children, and heterogeneity is common among tumors with similar morphology, according to Mustafa Barbour, M.D., pediatric hematologist/oncologist at Norton Children’s Cancer Institute, affiliated with the [...]
View more
The acute lymphoblastic leukemia link to obesity
Survivors of the most common childhood cancer, acute lymphoblastic leukemia (ALL), need long-term monitoring for obesity and other ongoing health consequences of their disease and treatment. “The etiology of obesity among ALL survivors is not […]
View more
Burkitt lymphoma, one of the more common forms of non-Hodgkin lymphoma, has a variety of clinical presentations
Burkitt lymphoma, an aggressive subtype of non-Hodgkin lymphoma (NHL), accounts for 40% of all NHL cases in the United States. This high-grade, fast-growing form of lymphoma starts in the immune system’s B cells and has […]
View more
Immunotherapy for refractory B-cell acute lymphoblastic leukemia
The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power [...]
View more
Don’t overlook these signs and symptoms of leukemia in children
Pediatricians can help with early detection of childhood leukemia during routine visits. Even though a patient’s signs and symptoms may appear vague, mild or suggestive of more common health conditions, they shouldn’t be ignored. In […]
View more
Reduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias
A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]
View more
Offering the latest childhood brain tumor therapies so kids and their families don’t have to travel far from home
Brain tumors are now the leading cause of cancer-related deaths among children. Year after year, Kentucky ranks among states with the highest incidence of children with brain tumors, and Kentucky currently ranks third in the [...]
View more
Optimizing leukemia/lymphoma care with a multidisciplinary team
The most effective way to optimize patient care revolves around a combination of physicians, nurses, pharmacists, nurse practitioners, social workers and case managers. Members of the team work together to help with decision-making in each […]
View more